Related Experiment Video
Updated: May 8, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Opioid withdrawal signs and symptoms in children: frequency and determinants
Deborah Fisher1, Mary Jo Grap, Janet B Younger
1Division of Pediatric Palliative Care, Children's Hospital of Richmond at VCU, Virginia Commonwealth University Medical Center, 1250 East Marshall Street, Richmond, VA 23298, USA.
Insights
Opioid withdrawal signs and symptoms were assessed in pediatric intensive care unit patients. While most children did not show daily withdrawal, common symptoms included diarrhea, vomiting, sweating, and fever.
Area of Science:
- Pediatric Intensive Care
- Pharmacology
- Clinical Assessment
Background:
- Opioids are frequently administered in pediatric intensive care units for pain management, sedation, and physiological support.
- Children can develop physical dependence on opioids within 2-3 days of continuous therapy.
- Opioid medications are gradually reduced when no longer medically necessary.
Purpose of the Study:
- To determine the frequency of opioid withdrawal signs and symptoms in a pediatric population.
- To identify factors associated with opioid withdrawal in children receiving opioid therapy.
Main Methods:
- A prospective, descriptive study was conducted with 26 pediatric patients (2 weeks to 21 years) in a pediatric intensive care unit.
- Patients received continuous or scheduled opioids for at least 5 days.
- Data included opioid withdrawal scores (WAT-1), taper rates, opioid exposure duration, and patient age.
Main Results:
- Only 45% of the 26 participants exhibited opioid withdrawal on any given day.
- The Waters Opioid Withdrawal (WAT-1) scores showed limited variability.
- The most frequently observed symptoms of opioid withdrawal were diarrhea, vomiting, sweating, and fever.
Conclusions:
- Clinicians should utilize validated instruments like the WAT-1 for accurate assessment of opioid withdrawal in children.
- Further research is necessary to identify specific risk factors for opioid withdrawal in pediatric patients.
Objectives:
The purpose of this study was to, in a pediatric population, describe the frequency of opioid withdrawal signs and symptoms and to identify factors associated with these opioid withdrawal signs and symptoms.
Background:
Opioids are used routinely in the pediatric intensive care population for analgesia, sedation, blunting of physiologic responses to stress, and safety. In children, physical dependence may occur in as little as 2-3 days of continuous opioid therapy. Once the child no longer needs the opioid, the medications are reduced over time.
Methods:
A prospective, descriptive study was conducted. The sample of 26 was drawn from all patients, ages 2 weeks to 21 years admitted to the Children's Hospital of Richmond pediatric intensive care unit (PICU) and who have received continuous infusion or scheduled opioids for at least 5 days. Data collected included: opioid withdrawal score (WAT-1), opioid taper rate (total dose of opioid per day in morphine equivalents per kilogram [MEK]), pretaper peak MEK, pretaper cumulative MEK, number of days of opioid exposure prior to taper, and age.
Results:
Out of 26 enrolled participants, only 9 (45%) had opioid withdrawal on any given day. In addition, there was limited variability in WAT-1 scores. The most common symptoms notes were diarrhea, vomit, sweat, and fever.
Conclusions:
For optimal opioid withdrawal assessments, clinicians should use a validated instrument such as the WAT-1 to measure for signs and symptoms of opioid withdrawal. Further research is indicated to examine risk factors for opioid withdrawal in children.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Oppositional Defiant Disorder
Diagnostic Criteria and...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
